DISCUSSION
hypoxaemia
In this post hoc exploratory sub‐study of the COVID STEROID 2 trial, we found no strong evidence for substantial HTE with higher (12 mg) versus lower (6 mg) doses of dexamethasone on days alive without life support or mortality at Day 90 in patients with COVID‐19 and severe hypoxaemia. All We previously hypothesised that higher doses of dexamethasone may be more beneficial in younger patients,Assessing HTE according to illness severity defined as the risk of poor outcomes has been recommended,